HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robert D E Sewell Selected Research

salicylaldehyde

10/2021Pharmacological evaluation of the gabapentin salicylaldehyde derivative, gabapentsal, against tonic and phasic pain models, inflammation, and pyrexia.
11/2017Gabapentin and its salicylaldehyde derivative alleviate allodynia and hypoalgesia in a cisplatin-induced neuropathic pain model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Robert D E Sewell Research Topics

Disease

7Hyperalgesia
01/2021 - 11/2015
7Neuralgia (Stump Neuralgia)
01/2021 - 11/2015
5Inflammation (Inflammations)
10/2021 - 01/2012
5Pain (Aches)
10/2021 - 10/2013
5Atherosclerosis
01/2020 - 01/2018
4Neoplasms (Cancer)
01/2019 - 11/2014
4Alzheimer Disease (Alzheimer's Disease)
01/2018 - 05/2007
4Parkinson Disease (Parkinson's Disease)
04/2014 - 04/2011
3Vomiting
01/2017 - 11/2014
3Neurodegenerative Diseases (Neurodegenerative Disease)
04/2014 - 08/2007
2Neuroinflammatory Diseases
01/2021 - 01/2018
2Ischemia
05/2020 - 01/2019
2Stroke (Strokes)
05/2020 - 01/2020
2Peripheral Nervous System Diseases (PNS Diseases)
01/2019 - 11/2017
2Cardiovascular Diseases (Cardiovascular Disease)
01/2019 - 01/2018
2Diabetes Mellitus
01/2018 - 11/2015
2Vulvodynia
02/2016 - 11/2015
2Dementia (Dementias)
01/2016 - 05/2007
2Body Weight (Weight, Body)
11/2015 - 07/2014
2Hypokinesia (Bradykinesia)
02/2015 - 04/2014
2Ulcer
07/2014 - 03/2014
1Fever (Fevers)
10/2021
1Edema (Dropsy)
10/2021
1Nociceptive Pain
10/2021
1Visceral Pain
10/2021
1Dysmenorrhea (Menstrual Pain)
01/2021
1Ataxia (Dyssynergia)
01/2021
1Gliosis
01/2021
1Arterial Occlusive Diseases (Arterial Occlusive Disease)
01/2020
1Central Nervous System Infections (Central Nervous System Infection)
01/2020
1Arbovirus Infections
01/2020
1Encephalitis (Encephalitis, Rasmussen)
01/2020
1Encephalomyelitis (Myeloencephalitis)
01/2020
1Meningitis
01/2020
1Meningoencephalitis
01/2020
1Virus Diseases (Viral Diseases)
01/2020
1Myelitis
01/2020
1Myocardial Infarction
01/2020
1Arteritis
01/2020
1Thrombosis (Thrombus)
01/2019
1Autism Spectrum Disorder
01/2019
1Atherosclerotic Plaque (Atheroma)
01/2019
1Infarction (Infarctions)
01/2019
1Autistic Disorder (Autism)
01/2019
1Insulin Resistance
01/2018

Drug/Important Bio-Agent (IBA)

9AntioxidantsIBA
05/2020 - 11/2014
6Gabapentin (Neurontin)FDA LinkGeneric
10/2021 - 11/2015
6Cisplatin (Platino)FDA LinkGeneric
01/2019 - 11/2014
4Proteins (Proteins, Gene)FDA Link
01/2021 - 01/2012
4Amyloid (Amyloid Fibrils)IBA
01/2018 - 08/2007
3Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
10/2021 - 03/2014
3Free RadicalsIBA
05/2020 - 01/2018
3Nitric Oxide (Nitrogen Monoxide)FDA Link
05/2020 - 01/2019
3CytokinesIBA
01/2020 - 01/2012
3Neurotransmitter Agents (Neurotransmitter)IBA
01/2019 - 05/2007
3SynucleinsIBA
04/2013 - 04/2011
3AutoantibodiesIBA
04/2013 - 05/2007
2Acetic Acid (Vinegar)FDA LinkGeneric
10/2021 - 01/2021
2CarrageenanIBA
10/2021 - 01/2021
2salicylaldehydeIBA
10/2021 - 11/2017
2Serotonin (5 Hydroxytryptamine)IBA
10/2021 - 05/2007
2Analgesics (Analgesic Drugs)IBA
01/2021 - 11/2017
2Messenger RNA (mRNA)IBA
01/2021 - 05/2020
2gamma-Aminobutyric Acid (GABA)IBA
01/2021 - 02/2016
2Antiviral Agents (Antivirals)IBA
01/2020 - 01/2020
2Plant ExtractsIBA
01/2019 - 01/2019
2FlavonoidsIBA
01/2019 - 11/2017
2CholesterolIBA
01/2019 - 01/2018
2Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2018 - 01/2018
2AntiemeticsIBA
01/2017 - 11/2014
2Streptozocin (Streptozotocin)FDA Link
02/2016 - 11/2015
2Dopamine (Intropin)FDA LinkGeneric
04/2014 - 04/2011
1Chlorpheniramine (Chlorphenamine)FDA LinkGeneric
10/2021
1Acetaminophen (Paracetamol)FDA LinkGeneric
10/2021
1Histamine (Histamine Dihydrochloride)FDA Link
10/2021
1AntipyreticsIBA
10/2021
1MianserinIBA
10/2021
1Mefenamic Acid (Pontal)FDA Link
01/2021
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2021
1Pharmaceutical PreparationsIBA
01/2021
1ThionesIBA
01/2021
1Brain-Derived Neurotrophic Factor (BDNF)IBA
05/2020
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
05/2020
1InflammasomesIBA
01/2020
1Biological ProductsIBA
01/2020
1LipidsIBA
01/2019
1LDL Lipoproteins (beta Lipoproteins)IBA
01/2019
1oxidized low density lipoproteinIBA
01/2019
1Synthetic DrugsIBA
01/2019
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
01/2019
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2019
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
01/2019
1Adrenergic Agents (Adrenergic Drugs)IBA
01/2019
1Glucose Transporter Type 4IBA
01/2018
1NitrogenIBA
01/2018
1AmylasesFDA Link
01/2018

Therapy/Procedure

5Drug Therapy (Chemotherapy)
01/2019 - 11/2014
2Aftercare (After-Treatment)
02/2015 - 04/2014
2Intrauterine Devices (Intrauterine Device)
01/2015 - 10/2013
1Therapeutics
01/2020